Clinical Trials Browser

Phase 1 × Recurrence × ublituximab × Clear all

NCT03804996 2024-04-08

Study of TG-1801 in Subjects With B-Cell Lymphoma

Phase 1 Completed

Recurrence, Lymphoma, B-Cell

NCT03778073 2022-08-22

Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma

Phase 1 Terminated

Recurrence, Lymphoma, B-Cell